Category: Feasibility

0

Complicated Urinary Tract Infection & Acute Pyelonephritis – Clinical Trial Feasibility

A Complicated Urinary Tract Infection (cUTI), a severe class of UTI, one of the most common infections in the world, is notorious and recognized as a menace globally. cUTI has relapsing and refractory characteristics and is sometimes life-threatening because of patient predisposing factors as well as the recent worldwide spread of multi-drug resistant bacteria. Pyelonephritis – infections of the […]

Read More →
4

Clinical Trial Feasibility – Important Tool Before You Conduct Clinical Trial

Conducting clinical trial feasibility is one of the first and crucial steps involved in any clinical study process. Clinical trial feasibility helps in assessing the potential of investigators, the country’s potential for conducting the trial, and many more aspects involved to execute a clinical trial successfully. Clinical trial feasibility Clinical trial feasibility is an assessment […]

Read More →
0

Psoriasis – Clinical Trial Feasibility

Approximately one-third of people with Psoriasis report being diagnosed before age 20. The prevalence of the disease in childhood and adolescence ranges between 0.5% and 2%. According to the World Psoriasis Day consortium 125 million people worldwide have Psoriasis. Psoriasis affects about 6.7 million Americans and is estimated to affect 2–4% of the population of […]

Read More →
0

Rosacea – Clinical Trial Feasibility

Rosacea is a common chronic inflammatory skin condition that causes redness and visible blood vessels on the face. It may also produce small, red, pus-filled bumps. Rosacea can be mistaken for acne, eczema, or a skin allergy. In the US more than 14 million people are estimated living with Rosacea. What is Rosacea? Rosacea is […]

Read More →
0

Diabetic Foot Ulcer – Clinical Trial Feasibility

Foot ulcers refer to a patch of broken-down skin usually on the lower leg or feet. In diabetics, when blood sugar levels are high or fluctuate regularly, skin that would normally heal may not properly repair itself because of nerve damage. therefore start a foot ulcer. It occurs in 15% of people with diabetes and precedes […]

Read More →
0

Glomerulonephritis – Clinical Trial Feasibility

Glomerulonephritis (GN) is a serious kidney disorder that can lead to end-stage renal disease (ESRD), serious morbidity, or death. Worldwide, IgA Nephropathy (Berger disease) is the most common cause of GN. IgA nephropathy is an autoimmune disease and is one of the most common kidney diseases, other than those caused by diabetes or high blood pressure. […]

Read More →
0

Pancreatitis – Global Clinical Trial Feasibility

Pancreatitis, inflammation of the pancreas, is the leading cause of GI-related hospitalizations in the USA and many other countries, with a medical condition requiring emergent care. The yearly incidence of Acute Pancreatitis in the United States and western countries is approximately 70-80 new cases per 100,000 population and has increased over the last decade. In […]

Read More →
1

Acute Myeloid Leukemia – Phase I/II Clinical Trial Feasibility

Acute myeloid leukemia (AML) is a cancer of the myeloid line of blood cells, characterized by the rapid growth of abnormal cells that build up in the bone marrow and blood that interfere with normal blood cells. It’s sometimes called acute myelocytic, myelogenous, or granulocytic leukemia. Causes of AML The causes of AML remain largely […]

Read More →
0

Epidermolysis bullosa – Clinical Trial Feasibility

Epidermolysis bullosa (EB) is a rare group of genetic disorders that cause the skin to be very fragile and to blister easily. It is a rare disease, and the condition was brought to public attention in 2004, in the UK through the Channel 4 documentary. It appears in many kinds of forms, and these forms are […]

Read More →
3

Feasibility Questionnaire: What Should You Know About and Include In It?

Clinical trial feasibility is a process to evaluate the possibility of conducting a clinical trial in a particular region, specific medical centers/site with an objective of optimum project completion in terms of timelines, targets and cost. This forms an integral and unavoidable step in beginning any clinical trial. Clinical trial feasibility is always facilitated by […]

Read More →